Estrosmart Plus
Natural health product licensed in Canada
- Other names
- CycleSmart
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80029413
- Status
- Active licence
- Licence date
- 6 February 2012
- Revision date
- 8 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Curcuma longa Source : Racine Extraction ratio : 50:1 Dry plant equivalent : 1,250 mg Potency : 95 % Curcuminoids | 25 milligramme | Not calculated |
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit Extraction ratio : 10:1 Dry plant equivalent : 400 mg Potency : 0.5 % Agnuside | 40 milligramme | Not calculated |
| 3,3'-Methylenebis-1H-indole Source : Di-indolymethane | 25 mg | Not calculated |
| Sel de calcium acide d-Glucarique Source : Calcium D-saccharate | 75 milligramme | Not calculated |
| Camellia sinensis Source : Feuilles de Camellia sinensis Potency : 70 % Catechins | Not specified | Not calculated |
| Camellia sinensis Source : Feuilles de Camellia sinensis Potency : 90 % polyphenols | Not specified | Not calculated |
| Camellia sinensis Source : Feuilles de Camellia sinensis Potency : 50 % epigallocatechin 3-gallate | Not specified | Not calculated |
Non-medicinal ingredients
Microcrystalline cellulose, Eau purifiée, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
ESTROSMART PLUS is a dietary supplement for the maintenance of good health and provides CChaste berry, used in Herbal Medicine to help relieve premenstrual symptoms, and as a hormone normaliser to help stabilise menstrual cycle irregularities. Helps support/promote healthy estrogen metabolism and supports/promotes a healthy estrogen metabolite ratio. Provides antioxidants. Provides factors for BPA detoxification. Used in Herbal Medicine to promote a healthy liver. Supports the production of desirable estrogen metabolism. Helps support glucuronidation, a liver detoxification pathway. Helps support estrogen metabolism by promoting a higher 2-hydroxyestrone to 16-hydroxyestrone ratio. Helps reduce the severity and duration of symptoms associated with cyclical mastalgia (recurrent breast pain)
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80029413
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.